Table 2.
Pre-Bed Rest | Post-Bed Rest | P Value | |
---|---|---|---|
Total protein | |||
Akt | 0.60 ± 0.12 | 0.65 ± 0.12 | 0.84 |
mTOR | 1.00 ± 0.28 | 1.44 ± 0.42 | 0.03 |
S6K1 | 1.22 ± 0.14 | 1.55 ± 0.25 | 0.10 |
4EBP1 | 0.42 ± 0.05 | 0.52 ± 0.09 | 0.13 |
rpS6 | 0.68 ± 0.20 | 0.97 ± 0.33 | 0.15 |
ATF4 | 1.00 ± 0.26 | 1.12 ± 0.14 | 0.47 |
LAT1 | 0.73 ± 0.23 | 1.02 ± 0.31 | 0.10 |
SNAT2 | 1.08 ± 0.49 | 1.41 ± 0.64 | 0.10 |
mRNA | |||
LAT1 | 1.07 ± 0.18 | 1.77 ± 0.31 | 0.06 |
SNAT2 | 1.15 ± 0.27 | 1.11 ± 0.30 | 0.86 |
Values are means ± SE; n = 6 subjects in each group.
Akt, protein kinase B; mTOR, mammalian target of rapamycin; 4EBP1, 4E binding protein 1; rpS6, ribosomal protein S6; ATF4, activating transcription factor 4; LAT1, L-type amino acid transporter 1; SNAT2, sodium-coupled neutral amino acid transporter 2.
P values were determined from a paired t-test (pre- vs. post-bed rest). Total protein data were calculated by normalizing arbitrary density units to an internal loading control. Postabsorptive mRNA data were determined from the 2−ΔΔCT method relative to pre-bed rest.